PFIZER INC — Regulatory Filings 2021

Mar 29, 2021

DEFA14A 1 c101335_defa14a.htm

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

Filed by the Registrant [X] Filed by a Party other than the Registrant [_]

Check the appropriate box:

[_]	Preliminary Proxy Statement
[_]	CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (as permitted by
Rule 14a-6(e)(2))
[_]	Definitive Proxy Statement
[X]	Definitive Additional Materials
[_]	Soliciting Material Pursuant to Section
240.14a-12

Pfizer Inc.

(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if Other Than the
Registrant)

Payment of Filing Fee (Check the appropriate box):

[X]	No fee required.
[_]	Fee computed on table below per Exchange Act Rules 14a-6(i)(1)
and 0-11.
1)	Title of each class of securities to which transaction
applies:
2)	Aggregate number of securities to which transaction applies:
3)	Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined):
4)	Proposed maximum aggregate value of transaction:
5)	Total fee paid:
[_]	Fee paid previously with preliminary materials:
[_]	Check box if any part of the fee is offset as provided by
Exchange Act Rule 0-11(a)(2) and identify the filing for which the
offsetting fee was paid previously. Identify the previous filing by
registration statement number, or the form or schedule and the date of its
filing.
	1)	Amount previously paid:
	2)	Form, Schedule or Registration Statement No.:
	3)	Filing Party:
	4)	Date
Filed:

Field: Page; Sequence: 1

Field: /Page

Margaret M. Madden 235 East 42 nd Street, New York, NY 10017

YOUR VOTE IS IMPORTANT TO US - PLEASE VOTE YOUR SHARES TODAY

Dear Fellow Pfizer Shareholder:

On April 22, 2021, Pfizer will hold its Annual Meeting of Shareholders. We value your input as a holder of Pfizer common stock and encourage you to review our proxy materials and cast your vote today. You can view our proxy materials at https://investors.pfizer.com/proxy .

For the reasons set forth in the 2021 Proxy Statement, the Board of Directors recommends that you vote:

•	“FOR” each director nominee;
•	“FOR” the ratification of the selection of KPMG LLP as the independent registered public accounting firm for 2021;
•	“FOR” the 2021 advisory approval of executive compensation; and
•	“AGAINST” the three shareholder proposals.

For your convenience, a duplicate proxy/voting instruction card and return envelope are enclosed, along with telephone and Internet voting instructions. In the event that multiple proxies/voting instruction cards are received from you, the one with the latest date will be counted.

In response to continued public health concerns related to the COVID-19 pandemic, and to support the health and well-being of our shareholders and other meeting participants, the 2021 Annual Meeting will be held in a virtual meeting format only. Please view our proxy statement for additional details on how you can participate.

Your vote is important and valued. I encourage you to vote in advance of the Annual Meeting by one of the methods described in the proxy materials and duplicate proxy/voting instruction card. Please act today to be sure your shares are voted.

Sincerely,

Margaret M. Madden

Senior Vice President and Corporate Secretary, Chief Governance Counsel

Breakthroughs that change patients’ lives pfizer.com

Field: Page; Sequence: 1

Field: /Page